Table 2 Univariate analysis of categorical variables according to the CPS status and the median API DM score (Chi2 test or Fisher's exact test) among the 115 patients.
CPS | API | ||||||
|---|---|---|---|---|---|---|---|
Active (n = 9) | Collaborative (n = 49) | Passive (n = 56) | p | Median DM score [Q1;Q3] | p | ||
Gender | Women | 2 (22.2%) | 18 (36.7%) | 19 (33.9%) | 0.76 | 41.7 [33.3;58.3] | 0.09 |
Men | 7 (77.8%) | 31 (63.3%) | 37 (66.1%) | 37.5 [25.0;45.8] | |||
Married | Yes | 6 (66.7%) | 35 (71.4%) | 45 (80.4%) | 0.47 | 41.7 [29.2;50.0] | 0.77 |
No | 3 (33.3%) | 14 (28.6%) | 11 (19.6%) | 37.5 [29.2;45.8] | |||
Occupational status | Employed | 3 (33.3%) | 9 (18.4%) | 15 (26.8%) | 0.0325 | 41.7 [29.2;58.3] | 0.66 |
Unemployed | 1 (11.1%) | 9 (18.4%) | 1 (1.8%) | 39.6 [27.1;52.1] | |||
Retired | 5 (55.6%) | 31 (63.3%) | 40 (71.4%) | 37.5 [27.1;45.8] | |||
Comorbidities treated by medication | Yes | 5 (55.6%) | 41 (83.7%) | 47 (83.9%) | 0.14 | 41.7 [37.5;54.2] | 0.18 |
No | 4 (44.4%) | 8 (16.3%) | 9 (16.1%) | 37.5 [25.0;45.8] | |||
Type of cancer | Hepatocellular carcinoma | 3 (33.3%) | 11 (22.4%) | 15 (26.8%) | 0.91 | 37.5 [25.0;45.8] | 0.44 |
Cholangiocarcinoma | 0 (0.00%) | 3 (6.1%) | 5 (8.9%) | 39.6 [25.0;45.8] | |||
Colorectal cancer | 5 (55.6%) | 25 (51.0%) | 21 (37.5%) | 41.7 [31.3;52.1] | |||
Stomach cancer | 0 (0.00%) | 0 (0.00%) | 2 (3.6%) | 29.2 [16.7;41.7] | |||
Pancreatic cancer | 1 (11.1%) | 9 (18.4%) | 12 (21.4%) | 37.5 [25.0;54.2] | |||
Oesophageal cancer | 0 (0.00%) | 1 (2.0%) | 1 (1.8%) | 22.9 [20.8;25.0] | |||
Metastatic status | Yes | 5 (55.6%) | 34 (69.4%) | 33 (58.9%) | 0.49 | 37.5 [29.2;50.0] | 0.38 |
No | 4 (44.4%) | 15 (30.6%) | 23 (41.1%) | 37.5 [25.0;45.8] | |||
Clinical trial | Yes | 1 (11.1%) | 11 (22.4%) | 8 (14.3%) | 0.56 | 37.5 [25.0;45.8] | 0.19 |
No | 8 (88.9%) | 38 (77.6%) | 48 (85.7%) | 41.7 [35.4;56.3] | |||
HADS anxiety | No symptom (≤ 7) | 6 (66.7%) | 23 (46.9%) | 31 (55.4%) | 0.63 | 37.5 [27.1;45.8] | 0.93 |
Doubtful symptomatology (8–10) | 1 (11.1%) | 17 (34.7%) | 17 (30.4%) | 39.6 [29.2;50.0] | |||
Definite symptomatology (≥ 11) | 2 (22.2%) | 9 (18.4%) | 8 (14.3%) | 37.5 [25.0;54.2] | |||
HADS depression | No symptom (≤ 7) | 7 (77.8%) | 35 (71.4%) | 41 (73.2%) | 0.98 | 37.5 [25.0;50.0] | 0.76 |
Doubtful symptomatology (8–10) | 1 (11.1%) | 9 (18.4%) | 8 (14.3%) | 37.5 [29.2;41.7] | |||
Definite symptomatology (≥ 11) | 1 (11.1%) | 5 (10.2%) | 7 (12.5%) | 37.5 [33.3;50.0] | |||
